(Q41024547)

25 September 2017

title

Sources of prediction error when using a Bayesian method to evaluate nortriptyline serum concentrations (English)

1 reference

25 September 2017

Kehoe WA

1

1 reference

25 September 2017

Harralson AF

series ordinal

2

1 reference

25 September 2017

Jacisin JJ

series ordinal

3

1 reference

25 September 2017

Duong TT

series ordinal

4

1 reference

25 September 2017

publication date

1 August 1994

1 reference

The Journal of Clinical Pharmacology

25 September 2017

published in

1 reference

25 September 2017

volume

34

1 reference

25 September 2017

issue

8

1 reference

25 September 2017

page(s)

842-847

1 reference

The relationship between antidepressant response and tricyclic antidepressant plasma concentrations. A retrospective analysis of the literature using logistic regression analysis

25 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1994.TB02049.X

Cost-benefit analysis of prospective pharmacokinetic dosing of nortriptyline in depressed inpatients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1994.TB02049.X

Prediction of maintenance dose required to attain a desired drug concentration at steady-state from a single determination of concentration after an initial dose.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1994.TB02049.X

Two prospective dosing methods for nortriptyline.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1994.TB02049.X

Dosage adjustment from simple nortriptyline spot level predictor tests in depressed patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1994.TB02049.X

Bayesian individualization of pharmacokinetics: simple implementation and comparison with non-Bayesian methods.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1994.TB02049.X

Some suggestions for measuring predictive performance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1994.TB02049.X

Forecasting individual pharmacokinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1994.TB02049.X

Recent developments in hepatic drug oxidation. Implications for clinical pharmacokinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1994.TB02049.X

Bayesian parameter estimation and population pharmacokinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1994.TB02049.X

Systematic Approach to the Psychopharmacologic Treatment of Resistant Depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1994.TB02049.X

10.1002/J.1552-4604.1994.TB02049.X

21 January 2018

Identifiers

DOI

1 reference

25 September 2017

1 reference